fda tirzepatide news Zepbound copycats remain online despite ban Tirzepatide drug fast-tracked for weight

Side effects continue to be a significant burden on the NHS and studies have shown they account for one in six hospital admissions

The pediatric indication requires dedicated clinical trials demonstrating safety and efficacy in that age group, which Wegovy has, and Ozempic does not, says Omodamola Aje, MD , a board-certified endocrinologist

There is need for long-term prospective trials of GLP-1 drugs to confirm efficacy in breast cancer prevention

Patients with heart failure, kidney disease, or other conditions requiring fluid restriction should follow their healthcare provider's specific guidance on fluid intake

However, stopping treatment often results in weight regain and return of appetite to pre-treatment levels

By improving energy, metabolism, and mental clarity, NAD+ helps you stay consistent with your GLP-1 therapy and maintain lifestyle changes that can create a foundation for long-term health